SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001959173-23-005166.pdf 0001959173-23-005166.rtf 0001959173-23-005166.xls
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001950047-23-005612.pdf 0001950047-23-005612.rtf
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001950047-23-005610.pdf 0001950047-23-005610.rtf 0001950047-23-005610.xls
144/A	Amendment to a previously filed 144	Dec 04, 2023	View HTML 0001959173-23-005181.pdf 0001959173-23-005181.rtf 0001959173-23-005181.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Dec 04, 2023	View HTML 0001193125-23-288522.pdf 0001193125-23-288522.rtf
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 05, 2023	View HTML 0001840315-23-000006.pdf 0001840315-23-000006.rtf
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0000929638-23-003383.pdf 0000929638-23-003383.rtf 0000929638-23-003383.xls
3	Initial filing by director officer or owner of more than ten percent	Dec 06, 2023	View HTML 0000929638-23-003382.pdf 0000929638-23-003382.rtf 0000929638-23-003382.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0001562180-23-008172.pdf 0001562180-23-008172.rtf 0001562180-23-008172.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0001562180-23-008171.pdf 0001562180-23-008171.rtf 0001562180-23-008171.xls

Data provided by Kaleidoscope.